Skip to main content
Caplight Logo









Therapixel

Therapixel

Private
NiceHealthcare & Life Scienceshttps://www.therapixel.com/

Last Round

Series B

May 12, 2022

Total Funding Raised

$23.1M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Therapixel is a healthtech company that provides AI-based medical imaging software to assist radiologists in breast cancer screening.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Medical AI

Business Model

B2B

Customer Profile

Usage-Based SaaS, Subscription SaaS

AI Layer

Application

Keywords

medical imaging AIbreast cancer screeningsoftware as a medical deviceSaMDradiology AIdigital mammographydiagnostic decision supportPACS integrationRIS integrationclinical decision supportusage-based SaaSmedtechAI-powered diagnosticsdeep learning imagingradiology workflow

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Therapixel Comparables

Compare Therapixel with similar companies based on industry and business-model similarity.

Therapixel comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ScreenPoint Medical
94%
Vara
91%
DeepLook Medical
88%

Therapixel Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BMay 12, 2022
Series AMar 13, 2019
GrantJun 2, 2017
SeedNov 21, 2015

Key People

Founding team and executive leadership

Matthieu Leclerc-Chalvet

CEO

Executive Team

Therapixel Investors

Notable investors and investment history

Therapixel investors
InvestorRounds
CapHorn InvestSeries B
Verve VenturesSeries B
Région Sud InvestissementSeed, Series A, Series B
Turenne GroupeSeed
Arnold VenturesGrant
M CapitalSeries B, Series A
Crédit Mutuel InnovationSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 246% MoM.

  • Oct 1, 2025

    Operating within CE mark and FDA regulated environment.

Therapixel Filings

Explore SEC and related filing metadata, where available.

Therapixel filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Therapixel's valuation, stock price, and market status.

Is Therapixel a public or private company?

Therapixel is a private company.

What is the current stock price of Therapixel?

Therapixel is a private company with no public stock price. No recent secondary market data is available.

How much is Therapixel worth (valuation)?

Valuation information for Therapixel is not publicly available.

Can I buy Therapixel stock?

Therapixel shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Therapixel's last funding round?

Therapixel's most recent funding round was Series B on May 12, 2022.

Who are the main investors in Therapixel?

Key investors in Therapixel include M Capital, Crédit Mutuel Innovation.

Will Therapixel IPO soon?

No public IPO plans have been announced for Therapixel.

How can I track Therapixel secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Therapixel's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNice
Employee Range45
Year Founded2013
Last FundingMay 12, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?